Reimbursement Intelligence http://reimbursementintelligence.com Just another WordPress site Tue, 15 May 2012 18:45:46 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 American Health & Drug Benefits, March/April 2012 http://reimbursementintelligence.com/2012/05/american-health-drug-benefits-marchapril-2012/ http://reimbursementintelligence.com/2012/05/american-health-drug-benefits-marchapril-2012/#comments Tue, 15 May 2012 01:37:02 +0000 reim3754 http://reimbursementintelligence.com/?p=1855 Trends in Biologic Therapies for Rheumatoid Arthritis Results from a Survey of Payers and Providers

]]> http://reimbursementintelligence.com/2012/05/american-health-drug-benefits-marchapril-2012/feed/ 0 PRESS RELEASE: May 15, 2012 http://reimbursementintelligence.com/2012/05/tofacitinib-to-be-positioned-after-anti-tnfs-say-payers-based-on-fda-panel-review-may-15-2012/ http://reimbursementintelligence.com/2012/05/tofacitinib-to-be-positioned-after-anti-tnfs-say-payers-based-on-fda-panel-review-may-15-2012/#comments Tue, 15 May 2012 01:18:29 +0000 reim3754 http://reimbursementintelligence.com/?p=1848 Tofacitinib to be positioned after anti-TNFs say payers based on FDA panel review

Featured in FiercePharma: Payers likely to throw up hurdles to Pfizer’s new RA drug

]]> http://reimbursementintelligence.com/2012/05/tofacitinib-to-be-positioned-after-anti-tnfs-say-payers-based-on-fda-panel-review-may-15-2012/feed/ 0 American Health & Drug Benefits, March/April 2012 http://reimbursementintelligence.com/2012/05/trends-in-biologic-therapies-for-rheumatoid-arthritis-results-from-a-survey-of-payers-and-providers-american-health-drug-benenfits-marchapril-2012/ http://reimbursementintelligence.com/2012/05/trends-in-biologic-therapies-for-rheumatoid-arthritis-results-from-a-survey-of-payers-and-providers-american-health-drug-benenfits-marchapril-2012/#comments Wed, 02 May 2012 23:13:26 +0000 reim3754 http://reimbursementintelligence.com/?p=1660 Trends in Biologic Therapies for Rheumatoid Arthritis: Results from a Survey of Payers and Providers

]]> http://reimbursementintelligence.com/2012/05/trends-in-biologic-therapies-for-rheumatoid-arthritis-results-from-a-survey-of-payers-and-providers-american-health-drug-benenfits-marchapril-2012/feed/ 0 WEBINAR – May 23, 2012 @ 1 PM ET – Assessing your Salesforce Reimbursement Effectiveness: How do customers view your company’s reimbursement IQ? http://reimbursementintelligence.com/2012/05/webinar-assessing-your-salesforce-reimbursement-effectiveness-how-do-customers-view-your-companys-reimbursement-iq/ http://reimbursementintelligence.com/2012/05/webinar-assessing-your-salesforce-reimbursement-effectiveness-how-do-customers-view-your-companys-reimbursement-iq/#comments Wed, 02 May 2012 17:29:07 +0000 reim3754 http://reimbursementintelligence.com/?p=1640 http://reimbursementintelligence.com/2012/05/webinar-assessing-your-salesforce-reimbursement-effectiveness-how-do-customers-view-your-companys-reimbursement-iq/feed/ 0 PRESS RELEASE: March 20, 2012 http://reimbursementintelligence.com/2012/03/press-release-march-20-2012/ http://reimbursementintelligence.com/2012/03/press-release-march-20-2012/#comments Tue, 20 Mar 2012 17:06:06 +0000 reim3754 http://reimbursementintelligence.com/?p=1383 Oral Small Molecules for RA Face High Price-Sensitivity Hurdles

]]> http://reimbursementintelligence.com/2012/03/press-release-march-20-2012/feed/ 0 PRESS RELEASE: February 17, 2012 http://reimbursementintelligence.com/2012/02/press-release-february-16-2012/ http://reimbursementintelligence.com/2012/02/press-release-february-16-2012/#comments Fri, 17 Feb 2012 02:49:46 +0000 thingee http://reimbursementintelligence.com/?p=1234 Payers Say Birth Control Mandate Will Increase Premiums

]]> http://reimbursementintelligence.com/2012/02/press-release-february-16-2012/feed/ 0 PRESS RELEASE: Dec. 2, 2011 http://reimbursementintelligence.com/2011/12/press-release-dec-2-2011/ http://reimbursementintelligence.com/2011/12/press-release-dec-2-2011/#comments Fri, 02 Dec 2011 14:01:42 +0000 reim3754 http://reimbursementintelligence.com/?p=1017 Payers Outlook for Lipitor Generic Strategy Not Rosy: Market Share Decline Coming Soon

]]> http://reimbursementintelligence.com/2011/12/press-release-dec-2-2011/feed/ 0 ONCOLOGY INSIGHT SERVICE 2012 – Reimbursement models, quality initiatives, payer and provider views of oncology pipeline and emerging endpoints. http://reimbursementintelligence.com/2011/11/oncology_insight_service_2012/ http://reimbursementintelligence.com/2011/11/oncology_insight_service_2012/#comments Wed, 30 Nov 2011 21:04:16 +0000 thingee http://reimbursementintelligence.com/?p=997 http://reimbursementintelligence.com/2011/11/oncology_insight_service_2012/feed/ 0 PRESS RELEASE: Nov. 30, 2011 http://reimbursementintelligence.com/2011/11/press-release-nov-30-2011/ http://reimbursementintelligence.com/2011/11/press-release-nov-30-2011/#comments Wed, 30 Nov 2011 15:12:56 +0000 reim3754 http://reimbursementintelligence.com/?p=921 Payers to Pharma: In Rheumatology, Innovations without Outcomes are Irrelevant

]]> http://reimbursementintelligence.com/2011/11/press-release-nov-30-2011/feed/ 0 PRESS RELEASE: Nov. 15, 2011 http://reimbursementintelligence.com/2011/11/press-release-nov-15-2011/ http://reimbursementintelligence.com/2011/11/press-release-nov-15-2011/#comments Tue, 15 Nov 2011 14:40:13 +0000 reim3754 http://reimbursementintelligence.com/?p=658 Real Endpoints invests in market research firm Reimbursement Intelligence

]]> http://reimbursementintelligence.com/2011/11/press-release-nov-15-2011/feed/ 0